Local plans mirror national enrollment trends
One-fourth of Akron Ohio's SummaCare enrollees are among the coveted younger population
On the morning of April 1, exchange enrollments for SummaCare, a health plan in Akron, Ohio, appeared to be mirroring national experiences that have been shared to date, according to CEO Marty Hauser, an MHE editorial advisor.
“We are seeing a lower number of ‘young’ members sign up, with our numbers showing about 14% of the enrollees in the combined age groups of under 25, and 18 to 25,” Hauser says.
Adding the age group of 26 to 34 year olds, the total percentage of “young” enrollees comes in just under 25%-which is on par with what the Department of Health and Human Services has been reporting nationally.
The largest number of SummaCare exchange enrollees in raw numbers and as a percentage continues to be in the age 55 to 64 group, followed by the second largest group in ages 45 to 54. Again, the Ohio plan follows the national trend.
Hauser says somewhere between 23% and 26% of the enrollees are not paying their premiums. To have active coverage, consumers must pay premiums directly to the insurers.
Conversations with Perry and Friends: Saar Mahna, J.D., MBA
July 7th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the "Conversations with Perry and Friends" podcast. In this episode, Cohen speaks with Saar Mahna, J.D., MBA, CEO and founder of Banjo Health, an artificial intelligence company focused on prior authorization.
Listen
Sexual Health and HIV Care Integration Key to Better Care | IAS 2025
July 14th 2025Integrating HIV and sexual health care is essential for improving outcomes, but global stigma, funding cuts—especially the defunding of USAID—and structural barriers like limited access and political resistance continue to hinder progress, experts emphasized at IAS 2025.
Read More
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
FDA Expands Kerendia’s Use to Treat Common Form of Heart Failure
July 14th 2025Kerendia was originally approved in July 2021 to reduce cardiovascular and kidney complications in patients with chronic kidney disease (CKD) associated with type 2 diabetes. This new approval extends its use to a broader patient population.
Read More
Black Women Can Successfully Be Started on Long-Acting Apretude for HIV PrEP | IAS 2025
July 14th 2025Increasing the use of Apretude among Black women requires not only expanding awareness of the long-acting PrEP regimen in various clinics but also providing more flexible scheduling and partnering with specialty pharmacies.
Read More
